Proton pump inhibitor use associated with increased infection risk in esophageal atresia

Proton pump inhibitor use associated with increased infection risk in esophageal atresia

Researchers found increased incidence of Clostridioides difficile infection among patients with esophageal atresia with or without tracheoesophageal fistula undergoing proton pump inhibitor therapy, according to a poster.“Esophageal atresia/tracheoesophageal fistula (EA/TEF) patients are at an increased risk for GERD and its associated complications. Current ESPGHAN-NASPGHAN consensus guidelines on management of gastrointestinal complications in children with EA/TEF recommend the use of PPI as first line therapy following surgical repair of EA/TEF for the first year of life,”Read More

Share on facebook
Share on twitter
Share on linkedin